UnitedHealth Group Stock Price Drops Again as the Health Insurance Giant’s Sickly Summer Continues

UnitedHealth Group stock price drops again as the health insurance giant’s sickly summer continues

UnitedHealthcare’s parent company, UnitedHealth Group, is in need of some bed rest this week. The company’s stock price (NYSE: UNH) has been knocked off its feet again after the American insurance giant reported disappointing quarterly results and offered 2025 earnings guidance that was significantly below investor expectations. Here’s what you need to know. UnitedHealth Group’s Q2 2025 earnings Today, UnitedHealth Group reported its second-quar…

Exclusive | UnitedHealth Group Is Under Criminal Investigation for Possible Medicare Fraud – The Wall Street Journal - Corruption By Cops

Exclusive | UnitedHealth Group Is Under Criminal Investigation for Possible Medicare Fraud  The Wall Street Journal Source link The post Exclusive | UnitedHealth Group Is Under Criminal Investigation for Possible Medicare Fraud – The Wall Street Journal first appeared on Corruption By Cops.

UnitedHealth Grew to Be a Leviathan. Then Came the Backlash.

(New York Times) – The conglomerate was viewed as one of the most successful companies in America, but patients are enraged and investors have lost faith in its business model. UnitedHealth Group emerged as a health care colossus over the past decade and a half, earning one of the highest stock market values in the nation. But in the last two years, it has been hit with just about every misfortune that can befall a company: A gargantuan cyberatt…

UnitedHealth aims to reassure investors as profits plunge, DOJ investigates its Medicare business – DG Verifications & Stats

In this article UNH Follow your favorite stocksCREATE FREE ACCOUNT UnitedHealth Group Chairman and CEO Stephen Hemsley will face the first real test Tuesday of his ability to regain investor confidence as the largest private U.S. insurer reports earnings. The Dow component has seen its share price cut nearly in half since mid-May, with the stock on pace for its worst year in more than a decade, after earnings in its flagship Medicare program an…